IP Library Granted Patent US 8,394,037
Granted Patent B2
US 8,394,037 · App. 12/616,318 · Granted Mar 12, 2013

Systems and devices for evaluating the integrity of a uterine cavity

Inventor: Akos Toth (Tata, HU)
Assignee: Minerva Surgical, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,394,037
App. No.
12/616,318
Granted
Mar 12, 2013
Kind
B2
Abstract

Methods, systems and devices for evaluating the integrity of a uterine cavity. A method comprises introducing transcervically a probe into a patient's uterine cavity, providing a flow of a fluid (e.g., CO 2 ) through the probe into the uterine cavity and monitoring the rate of the flow to characterize the uterine cavity as perforated or non-perforated based on a change in the flow rate. If the flow rate drops to zero or close to zero, this indicates that the uterine cavity is intact and not perforated. If the flow rate does not drop to zero or close to zero, this indicates that a fluid flow is leaking through a perforation in the uterine cavity into the uterine cavity or escaping around an occlusion balloon that occludes the cervical canal.

Claims (20)

1. A system for characterizing a patient uterus, comprising:

a probe having a distal end;

an expandable member at the distal end of the probe, the expandable member having an expansible-collapsible frame which supports a fluid-tight wall and being adapted to occupy a uterine cavity when expanded;

a source of a pressurized flow of a fluid;

an integrity test lumen located in the probe, connected to the source, and configured to deliver the fluid from the source to a region surrounding an exterior of the fluid-tight wall of the expandable member when the expansible-collapsible frame is expanded in the uterine cavity of a patient;

a flow sensor for measuring a flow rate of the fluid from the lumen into the region surrounding the fluid-tight wall of the expandable member when expanded in the uterine cavity; and

a controller operatively coupled to the flow sensor and to the source of the pressurized fluid flow, said controller being configured to (1) initiate a flow of fluid from the fluid source through the lumen into the uterus to the region surrounding the exterior of the fluid-tight wall of the expandable member after the expandable-collapsible frame has been expanded to cause the expandable member to occupy the uterine cavity and before neutral gas is delivered to an interior of the expandable member to enable ablation, and (2) measure the flow rate of the flow of fluid into the uterus region surrounding the exterior of the fluid-tight wall of the expandable member using the flow sensor, and (3) determine if the measured flow rate of the fluid flow into the region drops below a predetermined minimum threshold rate within a predetermined period of lime in the range from 1 second to 60 seconds, wherein the controller generates a signal indicating that the uterus is perforated if the flow rate fails to fall below said predetermined minimum threshold rate within said predetermined time period.

2. The system of claim 1 , wherein the signal is at least one of visual, aural and tactile.

3. The system of claim 1 , wherein the flow sensor is a mass flow sensor.

4. The system of claim 1 , wherein the controller generates a signal indicating that the uterus is not perforated if the flow rate drops below said predetermined minimum threshold rate within said predetermined period of time.

5. The system of claim 4 , wherein the signal is at least one of visual, aural and tactile.

6. The system of claim 1 , wherein the expandable member comprises a thin-wall dielectric which defines an energy-delivery surface for ablating uterine cavity tissue.

7. The system of claim 6 , wherein the energy-delivery surface is configured to deliver RF energy to the tissue via capacitive coupling.

8. The system of claim 6 , wherein the energy-delivery surface includes at least one electrode coupled to an RF generator.

9. The system of claim 6 , wherein the controller is configured to disable activation of the energy-delivery surface if the flow rate fails to fall below said predetermined minimum threshold rate within said predetermined time period.

10. The system of claim 9 , further comprising an override mechanism to override the disabling mechanism.

11. The system of claim 6 , wherein the controller is configured to enable activation of the energy-delivery surface if the flow rate falls below said predetermined minimum threshold rate within said predetermined time period.

12. The system of claim 11 , wherein the controller is configured to automatically activate the energy delivery surface if the flow rate falls below said predetermined minimum threshold rate within said predetermined time period.

13. The system of claim 8 , further comprising a source of neutral gas, wherein the controller is configured to deliver the neutral gas through a neutral gas lumen in the probe to an interior volume defined by the wall of the expandable member after the expandable-collapsible frame has been expanded.

14. The system of claim 13 , wherein the integrity test lumen in the probe provides the only flow path between the uterine cavity and a proximal end of the probe when the distal end of the probe is in the uterine cavity.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Feb 5, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: MINERVA SURGICAL, INC.
Reel/Frame 074721/0585 →
SECURITY INTEREST Recorded Jan 30, 2026
From: AXORA MEDICAL, INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 074537/0617 →
RELEASE OF SECURITY INTEREST Recorded Oct 12, 2021
From: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: MINERVA SURGICAL, INC.
Reel/Frame 057770/0451 →
SECURITY INTEREST Recorded Oct 8, 2021
From: MINERVA SURGICAL, INC.
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 057758/0137 →
SECURITY INTEREST Recorded Dec 31, 2019
From: MINERVA SURGICAL, INC.
To: ARES CAPITAL CORPORATION
Reel/Frame 051395/0275 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2010
From: TOTH, AKOS
To: MINERVA SURGICAL, INC.
Reel/Frame 023904/0796 →
Continuity (1)
Related Publication 20110112432A1 · May 12, 2011